White GC - Search Results

1

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients.

Astermark J, Berntorp E, White GC, Kroner BL; MIBS Study Group. Astermark J, et al. Among authors: white gc. Haemophilia. 2001 May;7(3):267-72. doi: 10.1046/j.1365-2516.2001.00510.x. Haemophilia. 2001. PMID: 11380630

2

Immune tolerance induction: What have we learned over time?

Brackmann HH, White GC 2nd, Berntorp E, Andersen T, Escuriola-Ettingshausen C. Brackmann HH, et al. Among authors: white gc 2nd. Haemophilia. 2018 Apr;24 Suppl 3:3-14. doi: 10.1111/hae.13445. Haemophilia. 2018. PMID: 29543371 Review.

3

Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs.

Lederman MM, Jackson JB, Kroner BL, White GC 3rd, Eyster ME, Aledort LM, Hilgartner MW, Kessler CM, Cohen AR, Kiger KP, et al. Lederman MM, et al. Among authors: white gc 3rd. J Infect Dis. 1995 Jul;172(1):228-31. doi: 10.1093/infdis/172.1.228. J Infect Dis. 1995. PMID: 7797917

4

Seventeen years' experience with Autoplex/Autoplex T: evaluation of inpatients with severe haemophilia A and factor VIII inhibitors at a major haemophilia centre.

White GC 2nd. White GC 2nd. Haemophilia. 2000 Sep;6(5):508-12. doi: 10.1046/j.1365-2516.2000.00438.x. Haemophilia. 2000. PMID: 11012694

5

Use of recombinant factor IX in subjects with haemophilia B undergoing surgery.

Ragni MV, Pasi KJ, White GC, Giangrande PL, Courter SG, Tubridy KL; Recombinant FIX Surgical Study Group. Ragni MV, et al. Among authors: white gc. Haemophilia. 2002 Mar;8(2):91-7. doi: 10.1046/j.1365-2516.2002.00587.x. Haemophilia. 2002. PMID: 11952843 Clinical Trial.

6

B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study.

Kessler CM, Gill JC, White GC 2nd, Shapiro A, Arkin S, Roth DA, Meng X, Lusher JM. Kessler CM, et al. Among authors: white gc 2nd. Haemophilia. 2005 Mar;11(2):84-91. doi: 10.1111/j.1365-2516.2005.01068.x. Haemophilia. 2005. PMID: 15810908 Clinical Trial.

7

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, Shapiro A, Scheibel E, White G 3rd, Lee M. Bray GL, et al. Blood. 1994 May 1;83(9):2428-35. Blood. 1994. PMID: 8167332 Free article. Clinical Trial.

8

Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.

White GC 2nd, Greenwood R, Escobar M, Frelinger JA. White GC 2nd, et al. Haematologica. 2000 Oct;85(10 Suppl):113-6. Haematologica. 2000. PMID: 11187862 Review.

9

A multicenter study of recombinant factor VIII (Recombinate(TM) ) in previously treated patients with hemophilia A.

White GC, Courter S, Bray GL, Lee M, Gomperts ED. White GC, et al. Haemophilia. 1997 Jul;3(3):232. doi: 10.1046/j.1365-2516.1997.t01-4-00125.x. Haemophilia. 1997. PMID: 27214819 No abstract available.

10

Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII.

Sultan Y, White GC, Aronstam A, Bosser C, Brackmann HH, Brochier G, Gormsen J, Mariani G, Roberts HR, Scarabin Y, et al. Sultan Y, et al. Among authors: white gc. Nouv Rev Fr Hematol (1978). 1986;28(2):85-9. Nouv Rev Fr Hematol (1978). 1986. PMID: 3090516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page